These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32769709)

  • 1. Ophthalmic manifestations and management of common and rare autoimmune syndromes.
    Seol Y; Lee R; Bielory BP
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):493-500. PubMed ID: 32769709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines in allergic conjunctivitis.
    Erdinest N; London N; Solomon A
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):516-527. PubMed ID: 32739979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic complications with laser-assisted in-situ keratomileusis.
    Bielory BP; O'Brien TP
    Curr Opin Allergy Clin Immunol; 2011 Oct; 11(5):483-91. PubMed ID: 21822133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review: topical ophthalmic use of cyclosporin A.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corneal complications after hematopoietic stem cell transplantation].
    Mittelviefhaus H; Auw-Hädrich C
    Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoid and cannabinoid impact on the ocular surface.
    Bielory L; Tabliago NRA
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):482-492. PubMed ID: 32796166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye.
    Mah FS; O'Brien T; Kim T; Torkildsen G
    Curr Med Res Opin; 2008 Feb; 24(2):441-7. PubMed ID: 18167176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future directions in therapeutic interventions for conjunctival inflammatory disorders.
    Pflugfelder SC; Stern ME
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):450-3. PubMed ID: 17873588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corneal ulcer in chronic graft-versus-host disease: treatment with collagen shields].
    Spraul CW; Lang GE; Lang GK
    Klin Monbl Augenheilkd; 1994 Sep; 205(3):161-6. PubMed ID: 7996821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe primary ocular surface involvement in Behcet disease.
    Zeng J; Chen B
    Optom Vis Sci; 2014 Dec; 91(12):e301-4. PubMed ID: 25279778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of cyclosporine 0.05% in various ocular surface disorders].
    Maĭchuk DIu; Vasil'eva OA; Shokirova MM
    Vestn Oftalmol; 2014; 130(2):68-71. PubMed ID: 24864503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current market trends in anterior ocular inflammatory disease landscape.
    Khan RS; Rizvi S; Syed BA; Bielory L
    Curr Opin Allergy Clin Immunol; 2019 Oct; 19(5):503-509. PubMed ID: 31232860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease.
    Azari AA; Karadag R; Kanavi MR; Nehls S; Barney N; Kim K; Longo W; Hematti P; Juckett M
    Cutan Ocul Toxicol; 2017 Jun; 36(2):152-156. PubMed ID: 27380960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular allergy and dry eye syndrome.
    Bielory L
    Curr Opin Allergy Clin Immunol; 2004 Oct; 4(5):421-4. PubMed ID: 15349042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What's new in ocular surface disease?].
    Messmer EM; Benitez-Del-Castillo JM; Lambiase A; Doan S
    Ophthalmologe; 2005 Mar; 102(3):293-300. PubMed ID: 15616816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry eye disease, a prominent manifestation of systemic autoimmune disorders.
    Bustamante-Arias A; Ruiz Lozano RE; Rodriguez-Garcia A
    Eur J Ophthalmol; 2022 Nov; 32(6):3142-3162. PubMed ID: 35300528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
    Shamloo K; Barbarino A; Alfuraih S; Sharma A
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4511-4519. PubMed ID: 31675422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corneal melting after ocular surgery in patients with auto-immune disorders].
    van der Meulen IJ; van Rooij J; Hazes JW; van Cleynenbreugel H; Geerards AJ; Remeyer L
    Ned Tijdschr Geneeskd; 2007 Apr; 151(16):920-3. PubMed ID: 17500345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.